{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:38:15Z","timestamp":1791430695268,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Optometry - Journal of the American Optometric Association"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.optm.2005.06.013","type":"journal-article","created":{"date-parts":[[2005,9,8]],"date-time":"2005-09-08T13:07:56Z","timestamp":1126184876000},"page":"450-460","source":"Crossref","is-referenced-by-count":30,"title":["Complications of intravitreal steroid injections"],"prefix":"10.1016","volume":"76","author":[{"given":"Michelle L.","family":"Reichle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.optm.2005.06.013_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.optm.2005.06.013_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","article-title":"Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema","volume":"132","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1395-3907.2003.0146.x","article-title":"Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic macular oedema","volume":"81","author":"Karacorlu","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.optm.2005.06.013_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","article-title":"Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema","volume":"136","author":"Jonas","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9394(02)01938-4","article-title":"Intravitreal triamcinolone for refractory pseudophakic macular edema","volume":"135","author":"Benhamou","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macuar edema associated with central retinal vein occlusion","volume":"136","author":"Park","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib8","first-page":"1217","article-title":"Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion","volume":"120","author":"Ip","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.86.2.247","article-title":"Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion","volume":"86","author":"Greenberg","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","article-title":"Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis","volume":"29","author":"Young","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinoone for uveitis cystoid macular edema","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.optm.2005.06.013_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3928\/1542-8877-20030901-11","article-title":"Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide","volume":"34","author":"Saraiva","year":"2003","journal-title":"Ophthalmic Surg Lasers Imag"},{"key":"10.1016\/j.optm.2005.06.013_bib13","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archopht.121.10.1491","article-title":"Intravitreal triamcinolone for radiation-induced macular edema","volume":"121","author":"Sutter","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib14","first-page":"1380","article-title":"Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy","volume":"119","author":"Martidis","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archopht.121.5.667","article-title":"A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration","volume":"121","author":"Gillies","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archopht.122.2.218","article-title":"Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration","author":"Jonas","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/bjo.87.4.462","article-title":"Intravitreal triamcinolone acetonide for age related macular degeneration","volume":"87","author":"Jonas","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0002-9394(00)00882-5","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy","volume":"131","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1034\/j.1600-0420.2003.00130.x","article-title":"Neovascular glaucoma treated by intravitreal triamcinolone acetonide","volume":"81","author":"Jonas","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.optm.2005.06.013_bib20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy","volume":"84","author":"Jonas","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1395-3907.2003.0108.x","article-title":"Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?","volume":"81","author":"Jonas","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.optm.2005.06.013_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/bjo.87.3.361","article-title":"Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis","volume":"87","author":"Degenring","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib23","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/archopht.121.11.1658","article-title":"Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasias","volume":"121","author":"Martinez","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9394(03)00389-1","article-title":"Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome","volume":"136","author":"Rechtman","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0002-9394(03)00899-7","article-title":"Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia","volume":"137","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s004170100293","article-title":"Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony","volume":"239","author":"Jonas","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajo.2003.08.035","article-title":"Intravitreal triamcinolone of serous retinal detachment in Vogt-Koyanagi-Harada syndrome","volume":"137","author":"Andrade","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archopht.122.3.336","article-title":"Safety of an intravitreal injection of triamcinolone","volume":"122","author":"Gillies","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib29","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archopht.121.9.1279","article-title":"Noninfectious endophthalmitis associated with intravitreal triamcinolone injection","volume":"121","author":"Roth","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","article-title":"Acute endophthalmitis following intravitreal triamcinolone acetonide injection","volume":"136","author":"Moshfeghi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib31","unstructured":"Yudcovitch LB. The role of steroids in optometric practice. Available at: http:\/\/www.opt.pacificu.edu\/ce\/catalog\/Steroids%20Yudcovitch\/SteroidsYudcovitch.html. Accessed May 14, 2004."},{"key":"10.1016\/j.optm.2005.06.013_bib32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2249.2000.01316.x","article-title":"Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line","volume":"121","author":"Penfold","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.optm.2005.06.013_bib33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ajo.2003.08.012","article-title":"Intraocular availability of triamcinolone acetonide after intravitreal injection","volume":"137","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1440-1606.1999.00238.x","article-title":"Intravitreal triamcinolone and elevated intraocular pressure","volume":"27","author":"Wingate","year":"1999","journal-title":"Aust NZ J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3928\/1542-8877-20030901-08","article-title":"The effect of intravitreal triamcinolone acetonide on intraocular pressure","volume":"34","author":"Bakri","year":"2003","journal-title":"Ophthalmic Surg Lasers Imag"},{"key":"10.1016\/j.optm.2005.06.013_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bjo.87.1.24","article-title":"Intraocular pressure after intravitreal injection of triamcinolone acetonide","volume":"87","author":"Jonas","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archopht.121.5.729","article-title":"Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.eye.6700654","article-title":"Cataract surgery after intravitreal injection of triamcinolone acetonide","volume":"18","author":"Jonas","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.optm.2005.06.013_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9394(14)72168-3","article-title":"Local therapy for cytomegalovirus retinopathy","volume":"120","author":"Engstrom","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archopht.121.2.271","article-title":"Endophthalmitis caused by mycobacterium chelonae abscessus after intravitreal injection of triamcinolone","volume":"121","author":"Benz","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib41","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/archopht.121.11.1663-b","article-title":"Endophthalmitis after intravitreal injection of triamcinolone acetonide","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2005.06.013_bib42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00417-003-0841-3","article-title":"Retinal complications of intravitreal injections of triamcinolone acetonide","volume":"242","author":"Jonas","year":"2004","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"}],"container-title":["Optometry - Journal of the American Optometric Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183905000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183905000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T06:10:43Z","timestamp":1626502243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529183905000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1529183905000321"],"URL":"https:\/\/doi.org\/10.1016\/j.optm.2005.06.013","relation":{},"ISSN":["1529-1839"],"issn-type":[{"value":"1529-1839","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}